Overview

Demeclocycline Fluorescence for Intraoperative Delineation Brain Tumors

Status:
Unknown status
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
This research study is studying a drug called Demeclocycline that may help brain surgeons see tumors with a microscope during surgery.
Phase:
Phase 1
Details
Lead Sponsor:
Massachusetts General Hospital
Treatments:
Demeclocycline